The DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.
An Update on the Roles of Non-albicans Candida Species in Vulvovaginitis
Open accessAbstract
Candida species are one of the commonest causes of vaginitis in healthy women of reproductive age. Vulvovaginal candidiasis (VVC) is characterized by vulvovaginal itching, redness and discharge. Candida albicans, which is a common genito-urinary tract commensal, has been the prominent species and remains the most common fungal agent isolated from clinical samples of patients diagnosed with VVC. In recent times, however, there has been a notable shift in the etiology of candidiasis with non-albicans Candida (NAC) species gaining prominence. The NAC species now account for approximately 10% to as high as 45% of VVC cases in some studies. This is associated with treatment challenges and a slightly different clinical picture. NAC species vaginitis is milder in presentation, often occur in patients with underlying chronic medical conditions and symptoms tend to be more recurrent or chronic compared with C. albicans vaginitis. C. glabrata is the most common cause of NAC-VVC. C. tropicalis, C. krusei, C. parapsilosis, and C. guilliermondii are the other commonly implicated species. Treatment failure is common in NAC-VVC, since some of these species are intrinsically resistant or show low susceptibilities to commonly used antifungal agents. This article reviews the etiology, pathogenesis, clinical features, diagnosis, and management of NAC vulvovaginitis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Given the increased accessibility of over-the-counter (OTC) antifungal therapy, some strains of Candida that were previously susceptible have become resistant, 12”
From Clinical challenges in diagnosis and treatment of recurrent vulvovaginal candidiasis (2022) · cites this paper as [12]
In the citing paper
“the prevalence of infection with non-albicans Candida (NAC) species is increasing.”
From Clinical challenges in diagnosis and treatment of recurrent vulvovaginal candidiasis (2022) · cites this paper as [12]
In the citing paper
“NAC species have been reported to be causative in approximately 10% of cases, with some studies citing up to 45% of VVC cases. 12”
From Clinical challenges in diagnosis and treatment of recurrent vulvovaginal candidiasis (2022) · cites this paper as [12]
In the citing paper
“Widespread use of broad-spectrum antibiotics coupled with increased availability of OTC and prescription antimycotic medications has fueled this shift. 12”
From Clinical challenges in diagnosis and treatment of recurrent vulvovaginal candidiasis (2022) · cites this paper as [12]
In the citing paper
“Alternative treatment options are limited because, as with azole-resistant strains, the current armamentarium of antifungal agents active against NAC strains is limited. 12”
From Clinical challenges in diagnosis and treatment of recurrent vulvovaginal candidiasis (2022) · cites this paper as [12]
In the citing paper
“In addition, non-albicans Candida species are frequently dose-dependent susceptible or resistant to fluconazole and other azoles, and their prevalence is rising.”
From Management of recurrent vulvovaginal candidosis: Narrative review of the literature and European expert panel opinion (2022) · cites this paper as Makanjuola et al., 2018
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pappas, P. G., Kauffman, C. A., Andes, D. R., Clancy, C. J., Marr, K. A., Ostrosky-Zeichner, L., Reboli, A. C., Schuster, M. G., Vazquez, J. A., Walsh, T. J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ933 · Cited by 4,200
Sexually Transmitted Diseases Treatment Guidelines, 2006
SKOLNIK, N. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-313-4_17 · Cited by 3,115
Kullberg, B. J., & Arendrup, M. C. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1315399 · Cited by 1,315
Sobel, J. D. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60917-9 · Cited by 1,270
Evolution of pathogenicity and sexual reproduction in eight Candida genomes
Butler, G., Rasmussen, M. D., Lin, M. F., Santos, M. A. S., Sakthikumar, S., Munro, C. A., Rheinbay, E., Grabherr, M., Forche, A., Reedy, J. L., et al. (2009) · Nature · doi:10.1038/nature08064 · Cited by 1,065
K -Profiles: A Nonlinear Clustering Method for Pattern Detection in High Dimensional Data
Wang, K., Zhao, Q., Lu, J., & Yu, T. (2015) · BioMed Research International · doi:10.1155/2015/918954 · Cited by 991
Silva, S., Negri, M., Henriques, M., Oliveira, R., Williams, D. W., & Azeredo, J. (2012) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2011.00278.x · Cited by 969
Fidel, P. L., Vazquez, J. A., & Sobel, J. D. (1999) · Clinical Microbiology Reviews · doi:10.1128/cmr.12.1.80 · Cited by 953
Potential Uses of Probiotics in Clinical Practice
Reid, G., Jaß, J., Sebulsky, M. T., & McCormick, J. K. (2003) · Clinical Microbiology Reviews · doi:10.1128/cmr.16.4.658-672.2003 · Cited by 918
1993 Sexually Transmitted Diseases Treatment Guidelines
(1994) · Journal of School Health · doi:10.1111/j.1746-1561.1994.tb03287.x · Cited by 918
Research works printed but not linked: 3
- Kenneth, J.R., and Ray, C.G. (2004). Candida, Aspergillus and other opportunistic fungi. Sherris Medical Microbiology: An Introduction to Infectious Diseases, McGraw-Hill. [4th ed.].
- Greenwood, D., Slack, R.C., Barer, M.R., and Irving, W.L. (2012). Fungi. Medical Microbiology: A Guide to Microbial Infections: Pathogenesis, Immunity, Laboratory Diagnosis and Control, Churchill Livingstone/Elsevier. [18th ed.].
- Hu, 2015, Molecular Characterization of Candida africana in Genital Specimens in Shanghai, China, BioMed Res. Int., 2015, 1
Cited by
Sorted by citations
Pekmezovic, M., Hovhannisyan, H., Gresnigt, M. S., Iracane, E., Oliveira-Pacheco, J., Siscar-Lewin, S., Seemann, E., Qualmann, B., Kalkreuter, T., Müller, S., et al. (2021) · Nature Microbiology · doi:10.1038/s41564-021-00875-2 · Cited by 96
Russo, R., Superti, F., Karadja, E., & De Seta, F. (2019) · Mycoses · doi:10.1111/myc.12883 · Cited by 94
Martens, M. G., Maximos, B., Degenhardt, T., Person, K., Curelop, S., Ghannoum, M., Flynt, A., & Brand, S. R. (2022) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2022.07.023 · Cited by 86
Schwebke, J. R., Sobel, R., Gersten, J. K., Sussman, S. A., Lederman, S. N., Jacobs, M. A., Chappell, B. T., Weinstein, D. L., Moffett, A. H., Azie, N. E., et al. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciab750 · Cited by 82
Donders, G., Sziller, I. O., Paavonen, J., Hay, P., de Seta, F., Bohbot, J. M., Kotarski, J., Vives, J. A., Szabo, B., Cepuliené, R., et al. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.934353 · Cited by 82
Candida parapsilosis complex in the clinical setting
Govrins, M. A., & Lass‐Flörl, C. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-023-00961-8 · Cited by 83
Ánh, Đ. N., Hung, D. N., Tien, T. V., Dinh, V. N., Son, V. T., Luong, N. V., Van, N. T. T., Quỳnh, N. T. N., Tuấn, N. V., Tuấn, L. Q., et al. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-06192-7 · Cited by 67
Gamal, A., Chu, S., McCormick, T. S., Borroto-Esoda, K., Angulo, D., & Ghannoum, M. A. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.642358 · Cited by 58
Maraki, S., Mavromanolaki, V. E., Stafylaki, D., Nioti, E., Hamilos, G., & Kasimati, A. (2019) · Mycoses · doi:10.1111/myc.12946 · Cited by 60
Clinical challenges in diagnosis and treatment of recurrent vulvovaginal candidiasis
Neal, C. M., & Martens, M. G. (2022) · SAGE Open Medicine · doi:10.1177/20503121221115201 · Cited by 56
Oral Ibrexafungerp: An Investigational Agent for the Treatment of Vulvovaginal Candidiasis
Azie, N., Angulo, D., Dehn, B., & Sobel, J. D. (2020) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2020.1791820 · Cited by 46
In vitroinfection models to study fungal–host interactions
Last, A., Maurer, M., Mosig, A. S., Gresnigt, M. S., & Hube, B. (2021) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuab005 · Cited by 45
Arastehfar, A. A., Kargar, M. L., Mohammadi, S. R., Roudbary, M., Ghods, N., Haghighi, L., Daneshnia, F., Tavakoli, M., Jafarzadeh, J., Hedayati, M. T., et al. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.655069 · Cited by 45
Insights into the role of sterol metabolism in antifungal drug resistance: a mini-review
Tanwar, S., Kalra, S., & Bari, V. K. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1409085 · Cited by 44
Zarrinfar, H., Kord, Z., & Fata, A. (2021) · Current Medical Mycology · doi:10.18502/cmm.7.3.7801 · Cited by 40
Inflammatory cytokine signalling in vulvovaginal candidiasis: a hot mess driving immunopathology
Cheng, K. O., Montaño, D. E., Zelante, T., Dietschmann, A., & Gresnigt, M. S. (2024) · Oxford Open Immunology · doi:10.1093/oxfimm/iqae010 · Cited by 41
Phase 2 Randomized Study of Oral Ibrexafungerp Versus Fluconazole in Vulvovaginal Candidiasis
Nyirjesy, P., Schwebke, J. R., Angulo, D. A., Harriott, I. A., Azie, N. E., & Sobel, J. D. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab841 · Cited by 38
Mushi, M. F., Olum, R., & Bongomin, F. (2022) · Medical Mycology · doi:10.1093/mmy/myac037 · Cited by 40
Self-citationValentine, M., Rudolph, P., Dietschmann, A., Tsavou, A., Mogavero, S., Lee, S., Priest, E. L., Zhurgenbayeva, G., Jablonowski, N., Timme, S., et al. (2024) · mBio · doi:10.1128/mbio.03409-23 · Cited by 38
Osman, A., Mohamed, M. S., Mallhi, T. H., Hussain, M. A., Jalloh, M. A., Omar, K. A., Alhaj, M. O., & Ali, A. A. M. M. (2022) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.15536 · Cited by 35
Antifungal susceptibility pattern of Candida species isolated from pregnant women
Ali, M., Edrees, W. H., Al-Shehari, W. A., Gao, X., Al-Hammadi, S., Qasem, E. A., Chaulagain, R. P., & Lal, N. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1434677 · Cited by 35
Paniágua, A. L., Correia, A. F., Pereira, L. C., de Alencar, B. M., Brandão, F., Almeida, R. M., & Nóbrega, Y. K. D. M. (2021) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-021-03405-z · Cited by 32
Shi, Y., Zhu, Y., Fan, S., Liu, X., Liang, Y., & Shan, Y. (2020) · BMC Infectious Diseases · doi:10.1186/s12879-020-04985-w · Cited by 32
Wang, X., Chen, L., Ruan, H., Xiong, Z., Wang, W., Qiu, J., Song, W., Zhang, C., Xue, F., Qin, T., et al. (2023) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00778-23 · Cited by 31
Patil, M., Rajput, A., Belgamwar, V. S., & Chalikwar, S. S. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e11489 · Cited by 28
Mohammadi, F., Hemmat, N., Bajalan, Z., & Javadi, A. (2021) · BioMed Research International · doi:10.1155/2021/5598907 · Cited by 30
Sobel, J. D., Borroto–Esoda, K., Azie, N. E., & Angulo, D. A. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00562-21 · Cited by 26
Ignjatović, A., Arsić-Arsenijević, V. S., Golubović, M., Đenić, S., Momčilović, S., Trajković, A., Ranđelović, M., Ćirić, V. M., & Otašević, S. (2020) · Journal of Fungi · doi:10.3390/jof6030113 · Cited by 25
Oral Ibrexafungerp for Vulvovaginal Candidiasis Treatment: An Analysis of VANISH 303 and VANISH 306
Goje, O., Sobel, R., Nyirjesy, P., Goldstein, S. R., Spitzer, M., Faught, B. M., Larson, S. B., King, T. R., Azie, N. E., Angulo, D. A., et al. (2022) · Journal of Women s Health · doi:10.1089/jwh.2022.0132 · Cited by 25
Ferreira, P. S., Victorelli, F. D., Rodero, C. F., Fortunato, G. C., Araújo, V. H. S., Fonseca‐Santos, B., Bauab, T. M., Dijck, P. V., & Chorilli, M. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120658 · Cited by 25
New Antifungals for Vulvovaginal Candidiasis: What Is Their Role?
Sobel, J. D. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciad002 · Cited by 23
Outpatient antifungal prescribing patterns in the United States, 2018
Benedict, K., Tsay, S. V., Bartoces, M. G., Vallabhaneni, S., Jackson, B. R., & Hicks, L. A. (2021) · Antimicrobial Stewardship & Healthcare Epidemiology · doi:10.1017/ash.2021.201 · Cited by 23
Soliman, M. F., Shetaia, Y. M., Tayel, A. A., Munshi, A. M., Alatawi, F. A., Alsieni, M., & Al‐Saman, M. A. (2022) · Antibiotics · doi:10.3390/antibiotics11030327 · Cited by 23
Paczkowska‐Walendowska, M., Chanaj-Kaczmarek, J., Romaniuk-Drapała, A., Rubiś, B., Szymanowska, D., Kobus‐Cisowska, J., Szymańska, E., Winnicka, K., & Cielecka‐Piontek, J. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9041208 · Cited by 23
Gharehbolagh, S. A., Fallah, B., Izadi, A., Ardestani, Z. S., Malekifar, P., Borman, A. M., & Mahmoudi, S. (2020) · PLoS ONE · doi:10.1371/journal.pone.0237046 · Cited by 23
van Riel, S. J. J. M., Lardenoije, C. M. J. G., Oudhuis, G. J., & Cremers, N. A. J. (2021) · Journal of Fungi · doi:10.3390/jof7080664 · Cited by 22
Gedefie, A., Shimeles, G., Motbainor, H., Kassanew, B., & Genet, C. (2025) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-024-07103-9 · Cited by 22
Su, S., Yan, H., Li, M., Wang, H., Chen, X., Shi, J., & Sun, S. (2021) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2021.1941868 · Cited by 22
Intra, J., Sala, M. R., Brambilla, P., Carcione, D., & Leoni, V. (2022) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2022.101278 · Cited by 24
Kan, S., Song, N., Pang, Q., Mei, H., Zheng, H., Li, D., Cui, F., Lv, G., An, R., Li, P., et al. (2023) · Mycopathologia · doi:10.1007/s11046-022-00687-w · Cited by 21
Kumar, K., Moirangthem, R., & Kaur, R. (2020) · PLoS Genetics · doi:10.1371/journal.pgen.1008620 · Cited by 21
An Association of an eBURST Group With Triazole Resistance of Candida tropicalis Blood Isolates
Tulyaprawat, O., Pharkjaksu, S., Chongtrakool, P., & Ngamskulrungroj, P. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00934 · Cited by 20
Chronic recurrent vulvovaginitis is not only due to Candida
Arechavala, A. I., Negroni, R., Santiso, G., Depardo, R., & Bonvehí, P. (2021) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2021.03.002 · Cited by 19
Kiasat, N., Rezaei‐Matehkolaei, A., & Mahmoudabadi, A. Z. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01678 · Cited by 19
Human albumin enhances the pathogenic potential of Candida glabrata on vaginal epithelial cells
Pekmezovic, M. G., Kaune, A.-K., Austermeier, S., Hitzler, S. U. J., Mogavero, S., Hovhannisyan, H., Gabaldón, T., Gresnigt, M. S., & Hube, B. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1010037 · Cited by 21
An Epidemiologic Analysis of Vulvovaginal Candidiasis and Antifungal Susceptibilities
Hösükoğlu, F. G., Ekşi, F., Erinmez, M., & Uğur, M. G. (2022) · Infectious Microbes & Diseases · doi:10.1097/im9.0000000000000095 · Cited by 18
Sathi, F. A., Paul, S. K., Ahmed, S., Alam, M. M., Nasreen, S. A., Haque, N., Islam, A., Nila, S. S., Afrin, S. Z., Aung, M. S., et al. (2022) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed7090211 · Cited by 20
Dunaiski, C. M., Kock, M. M., Jung, H., & Peters, R. P. H. (2022) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-022-01143-6 · Cited by 18
Aroca, J. J., Ramiro-Martínez, P., Esteban, L. M. M., González, A. M. F., García-Arata, I., & Menchero, S. P. (2020) · Revista Española de Quimioterapia · doi:10.37201/req/099.2019 · Cited by 20
Liu, Z., Yang, H., Huang, R., Li, X., Sun, T., & Zhu, L. (2025) · Clinical Microbiology Reviews · doi:10.1128/cmr.00284-24 · Cited by 17
Goje, O., Azie, N. E., Angulo, D. A., Sobel, R., Nyirjesy, P., & Sobel, J. D. (2025) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2025.07.040 · Cited by 16
Rolo, J., Faria-Gonçalves, P., Barata, T. S., Costa‐de‐Oliveira, S., Gaspar, C., Ferreira, S. S., Palmeira‐de‐Oliveira, R., Martinez‐de‐Oliveira, J., Costa‐de‐Oliveira, S., & Palmeira‐de‐Oliveira, A. (2021) · Microbial Drug Resistance · doi:10.1089/mdr.2020.0139 · Cited by 16
Frej−Mądrzak, M., Golec, S., Włodarczyk, K., Choroszy−Król, I., & Nawrot, U. (2021) · Pathogens · doi:10.3390/pathogens10091142 · Cited by 16
Recurrent Candida Vulvovaginitis
Nsenga, L., & Bongomin, F. (2022) · Venereology · doi:10.3390/venereology1010008 · Cited by 16
Self-citationZuzarte, M., Correia, P. M. P., Alves-Silva, J. M., Gonçalves, M. J., Cavaleiro, C., Cruz, M. T., & Salgueiro, L. (2021) · Antibiotics · doi:10.3390/antibiotics10050592 · Cited by 16
Song, N., Kan, S., Pang, Q., Mei, H., Zheng, H., Li, D., Cui, F., Lv, G., An, R., Li, P., et al. (2021) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.17874 · Cited by 16
Fernandes, M. Z., Caetano, C. F., Gaspar, C., Oliveira, A. S., Palmeira‐de‐Oliveira, R., Martinez‐de‐Oliveira, J., Rolo, J., & Palmeira‐de‐Oliveira, A. (2023) · Pathogens · doi:10.3390/pathogens12040595 · Cited by 15
Biochanin A Inhibits the Growth and Biofilm of Candida Species
Janeczko, M., & Kochanowicz, E. (2024) · Pharmaceuticals · doi:10.3390/ph17010089 · Cited by 16
Senthilganesh, J., RAVICHANDRAN, S., Rubini, D., BalaSubramaniyan, S., Krishnasamy, L., Veerappan, A., & Nithyanand, P. (2021) · Journal of Cluster Science · doi:10.1007/s10876-021-02061-0 · Cited by 15
de Araújo, P. R., Calixto, G. M. F., Araújo, V. H. S., Sato, M. R., Rodero, C. F., Oshiro, J. A., Bauab, T. M., & Chorilli, M. (2021) · Medical Mycology · doi:10.1093/mmy/myab006 · Cited by 14
Gerges, M. A., Fahmy, Y. A., Hosny, T., Gandor, N. H. M., Mohammed, S. Y., Ateya, R. M., Abdelmoteleb, N. E. M., & Esmaeel, N. E. (2023) · Infection and Drug Resistance · doi:10.2147/idr.s420580 · Cited by 15
Treatment of vaginitis caused by non-albicans Candida species
Sobel, J. D. (2024) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2024.2347953 · Cited by 14
Ranđelović, M., Dimitrijević, M., Otašević, S., Stanojevic, L. P., Išljamović, M., Ignjatović, A., Arsić-Arsenijević, V. S., & Stojanović-Radić, Z. Z. (2023) · Journal of Fungi · doi:10.3390/jof9111080 · Cited by 14
Zhang, J., Peng, J., Li, D., Mei, H., Yu, Y., Li, X., She, X., & Liu, W. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.894069 · Cited by 14
Chantanawilas, P., Pahumunto, N., Thananimit, S., & Teanpaisan, R. (2024) · Current Microbiology · doi:10.1007/s00284-024-03800-y · Cited by 12
Chen, Y., Wu, Y., Lulou, K., Yao, D., & Ying, C. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.808890 · Cited by 14
Dovo, E. E., Zohoncon, T. M., Tovo, S. F., Soubeïga, S. T., Kiendrebeogo, I. T., Yonli, A. T., Ouédraogo, R. A., Dabiré, A. M., Djigma, F. W., Nadembega, C., et al. (2022) · BMC Infectious Diseases · doi:10.1186/s12879-022-07619-5 · Cited by 16
Siddiqui, T., Kumar, K. A., Iqbal, A., Doultani, P. R., Ashraf, T., Eqbal, F., & Siddiqui, S. I. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e20495 · Cited by 11
Khalilzadeh, S., Eftkhar, T., Shirbeigi, L., Tabarrai, M., Toliyat, T., Fayazmanesh, S., Ghasemi, Z., & Shamohammadi, S. (2020) · Pharmaceutical Biology · doi:10.1080/13880209.2020.1784236 · Cited by 11
Memon, S., Farooqi, J. Q., Zafar, U., Naqvi, S. F., Zafar, A., & Jabeen, K. (2021) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001459 · Cited by 11
Liu, J., Zhang, H., Zhang, L., Li, T., Liu, N., & Liu, Q. (2023) · PeerJ · doi:10.7717/peerj.16444 · Cited by 11
Owoicho, O., Olwal, C. O., Tettevi, E. J., Atu, B. O., & Durugbo, E. U. (2022) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2022.2109963 · Cited by 11
Fanou, B. A., Klotoé, J. R., Dougnon, V. T., Monteiro, A., Koudokpon, H., & Loko, F. (2022) · Pan African Medical Journal · doi:10.11604/pamj.2022.42.215.28984 · Cited by 10
Spaggiari, L., Ardizzoni, A., Pedretti, N., Iseppi, R., Sabia, C., Russo, R., Kenno, S., Seta, F. D., & Pericolini, E. (2024) · Microorganisms · doi:10.3390/microorganisms12081634 · Cited by 10
Epidemiology of Vulvovaginal Candidiasis in Greece: A 2‐Year Single‐Centre Study
Kroustali, V., Resoulai, E., Kanioura, L., Siopi, M., Meletiadis, J., & Antonopoulou, S. (2025) · Mycoses · doi:10.1111/myc.70026 · Cited by 10
Li, X., Sholeh, M., Moghadam, M. A., Ostadrahimi, M., & Hosseini, S. S. (2026) · BMC Infectious Diseases · doi:10.1186/s12879-026-12653-8 · Cited by 12
Powell, A. M., Sarria, I., & Goje, O. (2023) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2023.02.005 · Cited by 10
Subedi, A., Upreti, M. K., Rana, J. C., Sapkota, R. P., & Shrestha, U. T. (2024) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2024.101509 · Cited by 10
Kroustali, V., Kanioura, L., Resoulai, E., Siopi, M., Antonopoulou, S., & Meletiadis, J. (2025) · Microbiology Spectrum · doi:10.1128/spectrum.02488-24 · Cited by 9
A Prerequisite for Health: Probiotics
Rossoni, R. D., Ribeiro, F. D. C., de Barros, P. P., Mylonakis, E. E., & Junqueira, J. C. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816664-2.00011-6 · Cited by 9
Meng, Q., Wang, H., Xiao, W., Mai, W., Liu, Y., Xiao, Y., Wang, P., Sui, J., He, X., Yin, F., et al. (2025) · Mycology · doi:10.1080/21501203.2025.2461725 · Cited by 8
Evaluation of overtime phenotypic variation of yeasts in chronic vulvovaginal candidosis cases
Faria-Gonçalves, P., Gaspar, C., Oliveira, A. S., Palmeira‐de‐Oliveira, R., Gonçalves, T., Martinez‐de‐Oliveira, J., Palmeira‐de‐Oliveira, A., & Rolo, J. (2021) · Medical Mycology · doi:10.1093/mmy/myab048 · Cited by 8
Chauhan, V., Kumar, A., Tripathi, S., Jha, M., Kumar, N., Poluri, K. M., & Gupta, P. (2024) · Discover Public Health · doi:10.1186/s12982-024-00274-y · Cited by 7
Update of Vulvovaginal Candidiasis in Pregnant and Non-pregnant Patients
Ramírez-Lozada, T., Espinosa-Hernández, V. M., León, M. G. F.-D., & Martínez-Herrera, E. O. (2019) · Current Fungal Infection Reports · doi:10.1007/s12281-019-00357-3 · Cited by 7
Pattern of Candida Species Isolated from Patient with Vulvovaginal Candidiasis in Pregnancy
Purnamasari, I., Ervianti, E., Damayanti, D., Prasetyo, B., Astari, L., Endraswari, P. D., Listiawan, M. Y., & Prakoeswa, C. R. S. (2022) · Berkala Ilmu Kesehatan Kulit dan Kelamin · doi:10.20473/bikk.v34.3.2022.178-183 · Cited by 6
Díaz-Huerta, H., García-Salazar, E., Ramírez-Magaña, X., Martínez-Herrera, E. O., Pinto‐Almazán, R., Betancourt-Cisneros, P., Duarte-Escalante, E., Reyes-Montes, M. D. R., Hernández‐Castro, R., & León, M. G. F.-D. (2025) · Journal of Fungi · doi:10.3390/jof11050354 · Cited by 6
Rachel, R., Murugesan, A., & Leela, K. V. (2024) · Journal of Pure and Applied Microbiology · doi:10.22207/jpam.18.1.20 · Cited by 6
Integrating Clinical and Microbiological Expertise to Improve Vaginal Candidiasis Management
Karakoyun, A. S., Ünal, N., Sucu, M., Bingöl, O., Ünal, İ., & İlkit, M. (2024) · Mycopathologia · doi:10.1007/s11046-024-00904-8 · Cited by 7
Tokak, S., Kılıç, İ. H., Horasanlı, J. E., MUTLU, E. G., Taşbent, F. E., & Karagöz, I. D. (2021) · Revista română de medicină de laborator · doi:10.2478/rrlm-2021-0012 · Cited by 6
Mucocutaneous Candida Infections in Immunocompromised Patients
Chahine, A., Farooqi, S., Marzvanyan, A., Michael, M., Chavez-Frazier, A., & Guzman, N. (2022) · Current Dermatology Reports · doi:10.1007/s13671-022-00356-7 · Cited by 6
de Souza, A. N. V., Faria, M. G. I., da Rocha, C. E., Philippsen, G. S., Silva, G. C. C., da Silva, G. R., Inumaro, R. S., Gonçalves, J. E., Gazim, Z. C., Wietzikoski, S., et al. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115403 · Cited by 6
Cerqueira, F., Medeiros, R., Lopes, I., Campos, C., Ferraz, M. P., Silva, F., Alves, L. G., & Pinto, E. (2024) · Antibiotics · doi:10.3390/antibiotics13030222 · Cited by 6
Quindós, G., Marcos‐Arias, C., Miranda-Cadena, K., Sevillano, E., Jauregizar, N., Schneider, J., & Eraso, E. (2025) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2025.2516554 · Cited by 5
Genetic diversity and antifungal resistance in Candida albicans from VVC cases in Indian women
Sahu, B. K., Mallick, U., Hegde, R., Turuk, J., Sahu, M. C., & Panda, S. K. (2025) · BMC Microbiology · doi:10.1186/s12866-025-04256-1 · Cited by 5
Asare, K. K., Bentil, H. A., Gyesi, E., Amoah, S., Bentsi-Enchill, F., & Opoku, Y. K. (2023) · BMC Women s Health · doi:10.1186/s12905-023-02253-y · Cited by 5
Strydom, M. B., Nelson, T. M., Khan, S. A., Walpola, R. L., Ware, R. S., & Tiralongo, E. (2024) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-024-04999-1 · Cited by 5
de Souza, C. M., Paulo, E. A., de Souza, N. A. A., dos Santos, M. M., Mantovani, M. S., Furlaneto-Maia, L., & Furlaneto, M. C. (2025) · Microbial Pathogenesis · doi:10.1016/j.micpath.2025.107807 · Cited by 4
Mbatudde, N., Nalumaga, P. P., Bazira, J., & Taseera, K. (2025) · Scientific Reports · doi:10.1038/s41598-025-09215-4 · Cited by 5
Vaginal dysbiosis-associated infections: Current and emerging treatment strategies
Peddakolmi, S., Shiraskar, O., & Bhor, V. M. (2025) · Journal of Reproductive Healthcare and Medicine · doi:10.25259/jrhm_32_2025 · Cited by 4
Zhu, W., & Guo, L. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1811011 · Cited by 5
Metadata
- Authors
- Makanjuola, O., Bongomin, F., & Fayemiwo, S.
- Affiliations
- University of Ibadan (NG)
- Gulu University (UG)
- Corresponding author
- Makanjuola, Olufunmilola
- Venue
- Journal of Fungi
- Publisher
- MDPI AG
- Published
- 2018-10-31
- Volume
- 4
- Issue
- 4
- Pages
- 121
- ISSN
- 2309-608X (ISSN-L)
- PMC
- PMC6309050
- OpenAlex
- W2899038225
- Cited by
- 182
- References
- 126
- Citations by year
- 2026: 23 · 2025: 27 · 2024: 26 · 2023: 21 · 2022: 31 · 2021: 33 · 2020: 14 · 2019: 6 · 2018: 1
- FWCI
- 1.98
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Journal of Fungi (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Immunology and Microbiology › Microbiology › Reproductive tract infections research
- Life Sciences › Immunology and Microbiology › Microbiology › Yeasts and Rust Fungi Studies
- Keywords
- non-albicans Candida, vaginal candidiasis, Candida glabrata, Candida tropicalis, Candida krusei, Candida parapsilosis, Candida guilliermondii, Candida albicans, antifungal resistance, recurrent vulvovaginal candidiasis, pathogenesis, diagnosis, treatment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
